Jan Mattsson

Insider Reports History

Location
Boston, MA
Signature
/s/ Jason Duncan, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jan Mattsson:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALBIREO PHARMA, INC. Chief Scientific Officer Common Stock 0 $43.80 02 Mar 2023 Direct
ALBIREO PHARMA, INC. Chief Scientific Officer Restricted Stock Units 0 02 Mar 2023 Direct
ALBIREO PHARMA, INC. Chief Scientific Officer Stock Option (Right to Buy) 0 02 Mar 2023 Direct

Insider Reports Filed by Jan Mattsson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALBO ALBIREO PHARMA, INC. 02 Mar 2023 8 $0 4 Chief Scientific Officer 02 Mar 2023, 15:43
ALBO ALBIREO PHARMA, INC. 23 Jan 2023 1 -$8,629 4 Chief Scientific Officer 23 Jan 2023, 16:11
ALBO ALBIREO PHARMA, INC. 19 Jan 2023 1 $0 4/A Chief Scientific Officer 27 Jan 2023, 16:28
ALBO ALBIREO PHARMA, INC. 19 Jan 2023 1 -$135,254 4 Chief Scientific Officer 20 Jan 2023, 15:05
ALBO ALBIREO PHARMA, INC. 24 Oct 2022 1 -$3,954 4 Chief Scientific Officer 25 Oct 2022, 16:00
ALBO ALBIREO PHARMA, INC. 22 Jul 2022 1 -$5,058 4 Chief Scientific Officer 25 Jul 2022, 16:23
ALBO ALBIREO PHARMA, INC. 22 Apr 2022 1 -$6,585 4 Chief Scientific Officer 25 Apr 2022, 16:41
ALBO ALBIREO PHARMA, INC. 24 Jan 2022 1 -$20,105 4 Chief Scientific Officer 25 Jan 2022, 15:37
ALBO ALBIREO PHARMA, INC. 18 Jan 2022 1 $0 4 Chief Scientific Officer 20 Jan 2022, 15:54